These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11712724)

  • 21. [Home palliative care--2 case reports: a long-term cancer pain management with transdermal fentanyl].
    Fujimoto M; Sakuyama T; Mizutani Y; Kuroda T; Yanaga K
    Gan To Kagaku Ryoho; 2004 Dec; 31 Suppl 2():190-3. PubMed ID: 15645768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effectiveness of transdermal fentanyl in palliative care.
    Evans R
    Nurs Times; 2003 Oct 14-20; 99(41):24-5. PubMed ID: 14603653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain.
    Ackerman SJ; Mordin M; Reblando J; Xu X; Schein J; Vallow S; Brennan M
    J Manag Care Pharm; 2003; 9(3):223-31. PubMed ID: 14613465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department.
    Borland M; Jacobs I; King B; O'Brien D
    Ann Emerg Med; 2007 Mar; 49(3):335-40. PubMed ID: 17067720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of cancer pain with transdermal fentanyl.
    Gourlay GK
    Lancet Oncol; 2001 Mar; 2(3):165-72. PubMed ID: 11902567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
    van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
    Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How should we use transdermal fentanyl (TF) for pain management in palliative care patients?
    Fainsinger RL; Bruera E
    J Palliat Care; 1996; 12(1):48-53. PubMed ID: 8857249
    [No Abstract]   [Full Text] [Related]  

  • 31. An alternative algorithm for dosing transdermal fentanyl for cancer-related pain.
    Breitbart W; Chandler S; Eagel B; Ellison N; Enck RE; Lefkowitz M; Payne R
    Oncology (Williston Park); 2000 May; 14(5):695-705; discussion 705, 709-17. PubMed ID: 10853461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Individual aspects of the quality of life of patients with chronic pain. Observational study of treatment with fentanyl-TTS].
    Zimmermann M; Waap I
    MMW Fortschr Med; 2005 Apr; 147 Suppl 1():33-40. PubMed ID: 16739370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients.
    Radbruch L; Sabatowski R; Petzke F; Brunsch-Radbruch A; Grond S; Lehmann KA
    Palliat Med; 2001 Jul; 15(4):309-21. PubMed ID: 12054148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of transdermal fentanyl on quality of life in rheumatoid arthritis.
    Berliner MN; Giesecke T; Bornhövd KD
    Clin J Pain; 2007; 23(6):530-4. PubMed ID: 17575494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating the effects of TTS-fentanyl for cancer pain on the psychological status of patients naïve to strong opioids: an open label study.
    Mystakidou K; Tsilika E; Parpa E; Papageorgiou C; Georgaki S; Vlahos L
    Cancer Nurs; 2004; 27(2):127-33. PubMed ID: 15253170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of intranasal fentanyl for the relief of pediatric orthopedic trauma pain.
    Saunders M; Adelgais K; Nelson D
    Acad Emerg Med; 2010 Nov; 17(11):1155-61. PubMed ID: 21175512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid switching from morphine to transdermal fentanyl for toxicity reduction in palliative care.
    McNamara P
    Palliat Med; 2002 Sep; 16(5):425-34. PubMed ID: 12380661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
    Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
    J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of a six-hour continuous overlap method for converting intravenous to transdermal fentanyl in cancer pain.
    Samala RV; Bloise R; Davis MP
    J Pain Symptom Manage; 2014 Jul; 48(1):132-6. PubMed ID: 24291296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Transdermal fentanyl for the management of cancer pain: a survey of 4492 patients].
    Yu SY; Sun Y; Wu YL; Qin SK; Xie GR; Liu SJ; Sui GJ; Zhang HC
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):369-72. PubMed ID: 16117902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.